Page last updated: 2024-10-22

1-aminoindan-1,5-dicarboxylic acid and Amyotrophic Lateral Sclerosis

1-aminoindan-1,5-dicarboxylic acid has been researched along with Amyotrophic Lateral Sclerosis in 1 studies

1-aminoindan-1,5-dicarboxylic acid: structure given in first source

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research Excerpts

ExcerptRelevanceReference
" The possible toxic factor(s) and the exact mode of action (e."1.33Protective effect of metabotropic glutamate receptor inhibition on amyotrophic lateral sclerosis-cerebrospinal fluid toxicity in vitro. ( Anneser, JM; Borasio, GD; Chahli, C, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anneser, JM1
Chahli, C1
Borasio, GD1

Other Studies

1 other study available for 1-aminoindan-1,5-dicarboxylic acid and Amyotrophic Lateral Sclerosis

ArticleYear
Protective effect of metabotropic glutamate receptor inhibition on amyotrophic lateral sclerosis-cerebrospinal fluid toxicity in vitro.
    Neuroscience, 2006, Sep-15, Volume: 141, Issue:4

    Topics: Aged; Amyotrophic Lateral Sclerosis; Animals; Cell Count; Cell Death; Cells, Cultured; Cerebrospinal

2006